X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES FRESENIUS KABI ONCO. JUBILANT LIFE SCIENCES/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 19.2 22.1 86.5% View Chart
P/BV x 4.6 3.1 148.6% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
FRESENIUS KABI ONCO.
Mar-13
JUBILANT LIFE SCIENCES/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs187176 106.1%   
Low Rs6579 82.9%   
Sales per share (Unadj.) Rs364.337.7 966.8%  
Earnings per share (Unadj.) Rs6.85.1 134.4%  
Cash flow per share (Unadj.) Rs24.56.7 364.4%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.942.5 387.6%  
Shares outstanding (eoy) m159.28158.23 100.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 10.2%   
Avg P/E ratio x18.425.0 73.6%  
P/CF ratio (eoy) x5.118.9 27.2%  
Price / Book Value ratio x0.83.0 25.5%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,06120,135 99.6%   
No. of employees `0006.21.2 536.9%   
Total wages/salary Rs m11,052703 1,571.6%   
Avg. sales/employee Rs Th9,383.05,176.2 181.3%   
Avg. wages/employee Rs Th1,786.9610.4 292.7%   
Avg. net profit/employee Rs Th176.3699.6 25.2%   
INCOME DATA
Net Sales Rs m58,0345,963 973.2%  
Other income Rs m19118 1,058.9%   
Total revenues Rs m58,2245,981 973.5%   
Gross profit Rs m5,7861,430 404.6%  
Depreciation Rs m2,812258 1,090.2%   
Interest Rs m3,237-26 -12,450.8%   
Profit before tax Rs m-721,216 -5.9%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-68 -3,149.6%   
Tax Rs m696342 203.5%   
Profit after tax Rs m1,090806 135.3%  
Gross profit margin %10.024.0 41.6%  
Effective tax rate %-965.928.1 -3,432.8%   
Net profit margin %1.913.5 13.9%  
BALANCE SHEET DATA
Current assets Rs m29,2805,102 573.9%   
Current liabilities Rs m38,9122,385 1,631.2%   
Net working cap to sales %-16.645.6 -36.4%  
Current ratio x0.82.1 35.2%  
Inventory Days Days84150 56.2%  
Debtors Days Days51113 44.7%  
Net fixed assets Rs m55,7125,148 1,082.2%   
Share capital Rs m155158 97.7%   
"Free" reserves Rs m20,9686,556 319.8%   
Net worth Rs m26,2656,732 390.2%   
Long term debt Rs m17,169952 1,803.1%   
Total assets Rs m88,60610,388 853.0%  
Interest coverage x1.0-45.8 -2.1%   
Debt to equity ratio x0.70.1 462.1%  
Sales to assets ratio x0.70.6 114.1%   
Return on assets %4.97.5 65.1%  
Return on equity %4.212.0 34.7%  
Return on capital %11.614.6 79.2%  
Exports to sales %37.874.5 50.7%   
Imports to sales %16.524.8 66.5%   
Exports (fob) Rs m21,9334,441 493.9%   
Imports (cif) Rs m9,5671,477 647.6%   
Fx inflow Rs m22,0045,298 415.4%   
Fx outflow Rs m11,7491,772 663.0%   
Net fx Rs m10,2553,525 290.9%   
CASH FLOW
From Operations Rs m8,0261,274 629.9%  
From Investments Rs m-1,744-1,204 144.8%  
From Financial Activity Rs m-4,447-196 2,267.9%  
Net Cashflow Rs m1,834-126 -1,452.5%  

Share Holding

Indian Promoters % 45.6 0.0 -  
Foreign collaborators % 3.5 81.0 4.3%  
Indian inst/Mut Fund % 8.7 0.3 2,900.0%  
FIIs % 21.2 9.6 220.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 9.1 231.9%  
Shareholders   23,815 42,599 55.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   TORRENT PHARMA  ALEMBIC PHARMA  ELDER PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Trade War Fears; Widening of Trade Deficit and Top Stocks in Action Today(Pre-Open)

Indian share markets trimmed their day's losses and ended flat on Friday amid weakness in their Asian peers, that wobbled on Friday as investors braced for US tariffs against China.

Related Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jun 15, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS